Integral Health Asset Management, LLC Zymeworks Inc. Transaction History

Integral Health Asset Management, LLC

  • $850 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$15.19 - $29.33 $759,500 - $1.47 Million
-50,000 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$27.35 - $37.28 $1.37 Million - $1.86 Million
50,000 New
50,000 $1.45 Million
Q1 2020

May 15, 2020
SELL
$24.28 - $49.8 $1.58 Million - $3.24 Million
-65,000 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$24.84 - $45.46 $1.61 Million - $2.95 Million
65,000 New
65,000 $2.96 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $872M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email